Concepedia

Dose Regimen Selection

Dose Regimen Selection is a methodological framework within clinical pharmacology that specifies the process of determining the optimal dosage, frequency, and duration of drug administration to achieve therapeutic efficacy while minimizing toxicity.

812

Publications

46.7K

Citations

5.6K

Authors

1.7K

Institutions

Publications per year

2017–2026

189

Parents

Publications

812

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

New England Journal of Medicine · 2010 · 3.2K citations · Full text

, , +16

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

New England Journal of Medicine · 2012 · 2.3K citations · Full text

, , +15

Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine

David W. Dodick, Stephen D. Silberstein, Marcelo E. Bigal et al. · JAMA · 2018 · 573 citations · Full text

, , +15

Efficacy of Methylprednisolone in Acute Spinal Cord Injury

Michael B. Bracken · JAMA · 1984 · 570 citations

, , +13

Oral Medroxyprogesterone Acetate in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Dose-Response Study by the Gynecologic Oncology Group

J.T. Thigpen, Mark F. Brady, Ronald D. Alvarez et al. · Journal of Clinical Oncology · 1999 · 483 citations

, , +15

1–5 of 812

Authors

5.6K

  1. JL
    Jen‐pei Liu

    National Health Research Institutes, Taiwan

    7 publications · 189 citations

    7

    h-index

  2. CH
    Chin‐Fu Hsiao

    National Health Research Institutes, Taiwan

    6 publications · 153 citations

    6

    h-index

  3. NJ
    Nicholas J. White

    Mahidol University, Thailand

    4 publications · 348 citations

    4

    h-index

  4. SM
    Sujata M. Bhavnani

    Institute for Clinical Pharmacodynamics (United States), United States

    4 publications · 219 citations

    4

    h-index

  5. PG
    Paul G. Ambrose

    Institute for Clinical Pharmacodynamics (United States), United States

    4 publications · 219 citations

    4

    h-index

1–5 of 5.6K

Institutions

1.7K

  1. Inserm

    Paris, France

    14 h-index

    88 publications

    5.4K citations

  2. Mahidol University

    Bangkok, Thailand

    13 h-index

    40 publications

    2.7K citations

  3. Novartis (Switzerland)

    Basel, Switzerland

    11 h-index

    55 publications

    4K citations

  4. University College London

    London, United Kingdom

    11 h-index

    30 publications

    726 citations

  5. Pfizer (United States)

    New York, United States

    11 h-index

    55 publications

    4.3K citations

  6. Merck & Co., Inc., Rahway, NJ, USA (United States)

    Rahway, United States

    9 h-index

    50 publications

    3K citations

  7. Cornell University

    Ithaca, United States

    9 h-index

    35 publications

    2.2K citations

  8. Karolinska Institutet

    Stockholm, Sweden

    8 h-index

    21 publications

    1.8K citations

1–8 of 1.7K

Venues

  1. PubMed

    Repository · 78 publications · 2.6K citations

    30

    h-index

  2. Journal of Clinical Oncology

    25 publications · 3.1K citations

    21

    h-index

  3. Antimicrobial Agents and Chemotherapy

    AAC · 24 publications · 855 citations

    16

    h-index

  4. Clinical Pharmacology & Therapeutics

    CPT · 14 publications · 632 citations

    13

    h-index

  5. Human Reproduction

    11 publications · 614 citations

    11

    h-index

1–5